GeneDx price target raised to $118 from $75 at TD Cowen

TD Cowen raised the firm’s price target on GeneDx (WGS) to $118 from $75 and keeps a Buy rating on the shares. The firm reviewed its financial model following the stock’s rise and believes there is room for upside noting its published trial studies support its strong competitive position.